Care
It provides sleep coaching and a sleep score among other new features.
In a blog post, the virtual care provider blasts the insurer for paying it less than other providers in California and refusing to process 'every single' out-of-network claim.
Boehringer Ingelheim and Click Therapeutics initiate clinical trial on PDTx treatment for schizophrenia and Akili's EndeavorRx shows promise for adults with ADHD.
Simon-Kucher's Jan Bordon and Kay Schultze discuss how to encourage uptake for digital health products.
Also, Startoon has obtained a US FDA clearance for its wearable recovery tracking device.
Also, Coviu and Alcidion have integrated their remote patient monitoring solutions.
The company reported a larger net loss in the first quarter that included a $330.3 million noncash goodwill impairment charge.
Diabetes management company Hygieia extended its Series B round, and Autonomize AI, a workflow platform for healthcare and life sciences, also announced funding.
The company reported $33.3 million in revenue for Q1 2023 and a net loss of $8.8 million.
The startup plans to file with the FDA to add other monitoring abilities and to introduce the product later this year.